China allows first stem cell injection into clinical test
　China's Ministry of Science and Technology and Ministry of Health announced in Beijing Tuesday that the country's first stem cell injection was allowed into phase I clinical test for leukemia patients.

　　Prof. Zhao Chunhua, principal investigator for cellular therapyresearch at the Chinese Academy of Medical Sciences, said at a news conference that the new drug, mesenchymal stem cell, won approval from the State Food and Drug Administration for the clinical test on Dec. 22 last year. The research is keeping up with other international medical researchers.

　　Zhao and his research team found multipotent adult progenitor cells exist in adult tissue and have numerous characters of embryonic stem cells.

　　Zhao further isolated a kind of cells which exist in most fetustissues and can be differentiated into multiple tissue cells when placed in a suitable environment.